US2020308608A1PendingUtilityA1
Use of serine proteases for improving ethanol yield
Est. expirySep 25, 2035(~9.2 yrs left)· nominal 20-yr term from priority
Inventors:Nathaniel KreelJoseph JumpMelissa Carrie HoossMadison RobertsBernardo Vidal, Jr.Kenneth JensenXinyan GuoHenrik FrisnerTine HoffYe LiuLan Tang
Y02E50/10C12N 9/62C13K 1/06C12N 15/63C12N 9/48C12Y 304/21C12P 7/06C12N 9/58C12Y 302/01001C12N 9/54C12P 2203/00C12N 9/2402C12Y 304/14C12N 9/50Y02E50/17
60
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The present invention relates to S53 proteases and to the use of S53 protease in processes for converting starch to ethanol.
Claims
exact text as granted — not AI-modified1 . A process for producing a fermentation product from starch-containing material comprising simultaneously saccharifying and fermenting starch-containing material using a carbohydrate-source generating enzymes and a fermenting organism at a temperature below the initial gelatinization temperature of said starch-containing material in the presence of a serine protease belonging to the S53 family.
2 . A process for producing a fermentation product from starch-containing material comprising the steps of:
(a) liquefying starch-containing material in the presence of an alpha-amylase; (b) saccharifying the liquefied material obtained in step (a) using a carbohydrate-source generating enzyme; (c) fermenting using a fermenting organism;
wherein a serine protease belonging to family 53 is present during step b) and/or c).
3 . The process of claim 1 or 2 , wherein the S53 protease is derived from a strain of the genus Meripilus, Trametes , Dichomitus, Polyporus, Lenzites, Ganoderma , Neolentinus, Lecanicillium, Talaromyces or Bacillus , more particularly Meripilus giganteus, Trametes versicolor, Dichomitus squalens, Polyporus arcularius, Lenzites betulinus, Ganoderma lucidum, Neolentinus lepideus , Lecanicillium sp WMM742, Talaromyces proteolyticus or Bacillus sp. 19138.
4 . The process of claim 1 or 2 , wherein the S53 protease is a polypeptide having serine protease activity, selected from the group consisting of:
(a) a polypeptide having at least 85%, at least 90%, at least 91%, at least 92%, at least 93%, at least 94%, 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100% sequence identity to the mature polypeptide of SEQ ID NO: 3;
(b) a polypeptide encoded by a polynucleotide having at least 85%, at least 90%, at least 91%, at least 92%, at least 93%, at least 94%, 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100% sequence identity to the mature polypeptide coding sequence of SEQ ID NO: 1.
5 . The process of claim 1 or 2 , wherein the S53 protease is a polypeptide having serine protease activity, selected from the group consisting of:
(a) a polypeptide having at least 85%, at least 90%, at least 91%, at least 92%, at least 93%, at least 94%, 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100% sequence identity to the mature polypeptide of SEQ ID NO: 6;
(b) a polypeptide encoded by a polynucleotide having at least 85%, at least 90%, at least 91%, at least 92%, at least 93%, at least 94%, 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100% sequence identity to the mature polypeptide coding sequence of SEQ ID NO: 4.
6 . The process of claim 1 or 2 , wherein the S53 protease is a polypeptide having serine protease activity, selected from the group consisting of:
(a) a polypeptide having at least 85%, at least 90%, at least 91%, at least 92%, at least 93%, at least 94%, 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100% sequence identity to the mature polypeptide of SEQ ID NO: 9;
(b) a polypeptide encoded by a polynucleotide having at least 85%, at least 90%, at least 91%, at least 92%, at least 93%, at least 94%, 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100% sequence identity to the mature polypeptide coding sequence of SEQ ID NO: 7.
7 . The process of claim 1 or 2 , wherein the S53 protease is a polypeptide having serine protease activity, selected from the group consisting of:
(a) a polypeptide having at least 85%, at least 90%, at least 91%, at least 92%, at least 93%, at least 94%, 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100% sequence identity to the mature polypeptide of SEQ ID NO: 12;
(b) a polypeptide encoded by a polynucleotide having at least 85%, at least 90%, at least 91%, at least 92%, at least 93%, at least 94%, 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100% sequence identity to the mature polypeptide coding sequence of SEQ ID NO: 10.
8 . The process of claim 1 or 2 , wherein the S53 protease is a polypeptide having serine protease activity, selected from the group consisting of:
(a) a polypeptide having at least 85%, at least 90%, at least 91%, at least 92%, at least 93%, at least 94%, 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100% sequence identity to the mature polypeptide of SEQ ID NO: 15;
(b) a polypeptide encoded by a polynucleotide having at least 85%, at least 90%, at least 91%, at least 92%, at least 93%, at least 94%, 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100% sequence identity to the mature polypeptide coding sequence of SEQ ID NO: 13.
9 . The process of claim 1 or 2 , wherein the S53 protease is a polypeptide having serine protease activity, selected from the group consisting of:
(a) a polypeptide having at least 85%, at least 90%, at least 91%, at least 92%, at least 93%, at least 94%, 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100% sequence identity to the mature polypeptide of SEQ ID NO: 26;
(c) a polypeptide encoded by a polynucleotide having at least 85%, at least 90%, at least 91%, at least 92%, at least 93%, at least 94%, 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100% sequence identity to the mature polypeptide coding sequence of SEQ ID NO: 25.
10 . The process of claim 1 or 2 , wherein the S53 protease is a polypeptide having serine protease activity, selected from the group consisting of:
(a) a polypeptide having at least 85%, at least 90%, at least 91%, at least 92%, at least 93%, at least 94%, 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100% sequence identity to the mature polypeptide of SEQ ID NO: 30;
(b) a polypeptide encoded by a polynucleotide having at least 85%, at least 90%, at least 91%, at least 92%, at least 93%, at least 94%, 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100% sequence identity to the mature polypeptide coding sequence of SEQ ID NO: 29.
11 . The process of claim 1 or 2 , wherein the S53 protease is a polypeptide having serine protease activity, selected from the group consisting of:
(a) a polypeptide having at least 85%, at least 90%, at least 91%, at least 92%, at least 93%, at least 94%, 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100% sequence identity to the mature polypeptide of SEQ ID NO: 34;
(b) a polypeptide encoded by a polynucleotide having at least 85%, at least 90%, at least 91%, at least 92%, at least 93%, at least 94%, 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100% sequence identity to the mature polypeptide coding sequence of SEQ ID NO: 33.
12 . The process of claim 1 or 2 , wherein the S53 protease is a polypeptide having serine protease activity, selected from the group consisting of:
(a) a polypeptide having at least 85%, at least 90%, at least 91%, at least 92%, at least 93%, at least 94%, 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100% sequence identity to the mature polypeptide of SEQ ID NO: 38, such as amino acids 195 to 560 or 190 to 560 of SEQ ID NO: 38.
13 . The process of claim 1 or 2 , wherein the S53 protease is a polypeptide having serine protease activity, selected from the group consisting of:
(a) a polypeptide having at least 85%, at least 90%, at least 91%, at least 92%, at least 93%, at least 94%, 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100% sequence identity to the mature polypeptide of SEQ ID NO: 39, such as amino acids 226 to 647 or 221 to 647 of SEQ ID NO: 39.
14 . (canceled)
15 . (canceled)
16 . (canceled)
17 . The process of claim 1 , wherein the fermentation product is an alcohol.
18 . A composition comprising a S53 protease and a carbohydrate-source generating enzyme and optionally an alpha-amylase.
19 . The composition of claim 18 , wherein the S53 protease is derived from a strain of the genus Meripilus, Trametes, Dichomitus, Polyporus, Lenzites, Ganoderma, Neolentinus Lecanicillium, Talaromyces or Bacillus , more particularly Meripilus giganteus, Trametes versicolor, Dichomitus squalens, Polyporus arcularius, Lenzites betulinus, Ganoderma lucidum, Neolentinus lepideus, Lecanicillium sp WMM742, Talaromyces proteolyticus or Bacillus sp. 19138.
20 . (canceled)
21 . A polypeptide having serine protease activity, selected from the group consisting of:
(a) a polypeptide having at least 85%, at least 90%, at least 91%, at least 92%, at least 93%, at least 94%, 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100% sequence identity to the polypeptide of SEQ ID NO: 12; (b) a polypeptide encoded by a polynucleotide having at least 85%, at least 90%, at least 91%, at least 92%, at least 93%, at least 94%, 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100% sequence identity to the mature polypeptide coding sequence of SEQ ID NO: 10; (c) a polypeptide having at least 85%, at least 90%, at least 91%, at least 92%, at least 93%, at least 94%, 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100% sequence identity to the polypeptide of SEQ ID NO: 15; (d) a polypeptide encoded by a polynucleotide having at least 85%, at least 90%, at least 91%, at least 92%, at least 93%, at least 94%, 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100% sequence identity to the mature polypeptide coding sequence of SEQ ID NO: 13; (e) a polypeptide having at least 85%, at least 90%, at least 91%, at least 92%, at least 93%, at least 94%, 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100% sequence identity to the polypeptide of SEQ ID NO: 27; (f) a polypeptide encoded by a polynucleotide having at least 85%, at least 90%, at least 91%, at least 92%, at least 93%, at least 94%, 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100% sequence identity to the mature polypeptide coding sequence of SEQ ID NO: 25; (g) a polypeptide having at least 85%, at least 90%, at least 91%, at least 92%, at least 93%, at least 94%, 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100% sequence identity to the polypeptide of SEQ ID NO: 31; and (h) a polypeptide encoded by a polynucleotide having at least 85%, at least 90%, at least 91%, at least 92%, at least 93%, at least 94%, 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100% sequence identity to the mature polypeptide coding sequence of SEQ ID NO: 29
22 . (canceled)
23 . (canceled)
24 . (canceled)
25 . A polypeptide having serine protease activity, selected from the group consisting of:
(a) a polypeptide having at least 85%, at least 90%, at least 91%, at least 92%, at least 93%, at least 94%, 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100% sequence identity to the mature polypeptide of SEQ ID NO: 38, such as amino acids 195 to 560 or 190 to 560 of SEQ ID NO: 38.
26 . A polypeptide having serine protease activity, selected from the group consisting of:
(a) a polypeptide having at least 85%, at least 90%, at least 91%, at least 92%, at least 93%, at least 94%, 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100% sequence identity to the mature polypeptide of SEQ ID NO: 39, such as amino acids 226 to 647 or 221 to 647 of SEQ ID NO: 39.
27 . (canceled)
28 . (canceled)
29 . A nucleic acid construct or expression vector comprising a polynucleotide encoding a polypeptide of claim 21 , wherein the polypeptide is operably linked to one or more control sequences that direct the production of the polypeptide in an expression host.
30 . A recombinant host cell comprising the polynucleotide of claim 21 operably linked to one or more control sequences that direct the production of the polypeptide.
31 . The process according to claim 1 wherein the S53 protease is an endo-protease.Join the waitlist — get patent alerts
Track US2020308608A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.